These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38051379)

  • 1. Tracking of apolipoprotein B levels measured in childhood and adolescence: systematic review and meta-analysis.
    Stanesby O; Zhou Z; Fonseca R; Kidokoro T; Otahal P; Fraser BJ; Wu F; Juonala M; Viikari JSA; Raitakari OT; Tomkinson GR; Magnussen CG
    Eur J Pediatr; 2024 Feb; 183(2):569-580. PubMed ID: 38051379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracking of serum lipid levels from childhood to adulthood: Systematic review and meta-analysis.
    Stanesby O; Armstrong MK; Otahal P; Goode JP; Fraser BJ; Negishi K; Kidokoro T; Winzenberg T; Juonala M; Wu F; Kelly RK; Xi B; Viikari JSA; Raitakari OT; Daniels SR; Tomkinson GR; Magnussen CG
    Atherosclerosis; 2024 Apr; 391():117482. PubMed ID: 38569384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B With Cardiovascular Disease Occurrence in Adults: Korean Genome and Epidemiology Study.
    Yun SY; Rim JH; Kang H; Lee SG; Lim JB
    Ann Lab Med; 2023 May; 43(3):237-243. PubMed ID: 36544335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Translational Tool to Facilitate Use of Apolipoprotein B for Clinical Decision-Making.
    Cole J; Otvos JD; Remaley AT
    Clin Chem; 2023 Jan; 69(1):41-47. PubMed ID: 36366949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concordance/discordance between serum apolipoprotein B, low density lipoprotein cholesterol and non-high density lipoprotein cholesterol in NATPOL 2011 participants - An epidemiological perspective.
    Solnica B; Sniderman AD; Wyszomirski A; Rutkowski M; Chlebus K; Bandosz P; Pencina MJ; Zdrojewski T
    Int J Cardiol; 2023 Nov; 390():131150. PubMed ID: 37429441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol.
    Fonseca L; Paredes S; Ramos H; Oliveira JC; Palma I
    Lipids Health Dis; 2020 Jun; 19(1):127. PubMed ID: 32505210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein B is associated with carotid atherosclerosis progression independent of individual cholesterol measures in a 9-year prospective study of Multi-Ethnic Study of Atherosclerosis participants.
    Steffen BT; Guan W; Remaley AT; Stein JH; Tattersall MC; Kaufman J; Tsai MY
    J Clin Lipidol; 2017; 11(5):1181-1191.e1. PubMed ID: 28826575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.
    Pischon T; Girman CJ; Sacks FM; Rifai N; Stampfer MJ; Rimm EB
    Circulation; 2005 Nov; 112(22):3375-83. PubMed ID: 16316964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study.
    Quispe R; Martin SS; Michos ED; Lamba I; Blumenthal RS; Saeed A; Lima J; Puri R; Nomura S; Tsai M; Wilkins J; Ballantyne CM; Nicholls S; Jones SR; Elshazly MB
    Eur Heart J; 2021 Nov; 42(42):4324-4332. PubMed ID: 34293083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordance among apoB, non-high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular prevention.
    Sniderman AD; Dufresne L; Pencina KM; Bilgic S; Thanassoulis G; Pencina MJ
    Eur Heart J; 2024 Jul; 45(27):2410-2418. PubMed ID: 38700053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment.
    Carr SS; Hooper AJ; Sullivan DR; Burnett JR
    Pathology; 2019 Feb; 51(2):148-154. PubMed ID: 30595507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease.
    Welsh C; Celis-Morales CA; Brown R; Mackay DF; Lewsey J; Mark PB; Gray SR; Ferguson LD; Anderson JJ; Lyall DM; Cleland JG; Jhund PS; Gill JMR; Pell JP; Sattar N; Welsh P
    Circulation; 2019 Aug; 140(7):542-552. PubMed ID: 31216866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordance between apolipoprotein B or non-HDL-cholesterol and LDL-cholesterol in middle-aged and elderly Chinese patients predicts arterial stiffness.
    Qu G; Zhang Z; Zhu H
    Lipids Health Dis; 2021 Jul; 20(1):80. PubMed ID: 34325713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.
    Boekholdt SM; Arsenault BJ; Mora S; Pedersen TR; LaRosa JC; Nestel PJ; Simes RJ; Durrington P; Hitman GA; Welch KM; DeMicco DA; Zwinderman AH; Clearfield MB; Downs JR; Tonkin AM; Colhoun HM; Gotto AM; Ridker PM; Kastelein JJ
    JAMA; 2012 Mar; 307(12):1302-9. PubMed ID: 22453571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The extended lipid panel assay: a clinically-deployed high-throughput nuclear magnetic resonance method for the simultaneous measurement of lipids and Apolipoprotein B.
    Garcia E; Bennett DW; Connelly MA; Jeyarajah EJ; Warf FC; Shalaurova I; Matyus SP; Wolak-Dinsmore J; Oskardmay DN; Young RM; Sampson M; Remaley AT; Otvos JD
    Lipids Health Dis; 2020 Dec; 19(1):247. PubMed ID: 33261644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content.
    Marston NA; Giugliano RP; Melloni GEM; Park JG; Morrill V; Blazing MA; Ference B; Stein E; Stroes ES; Braunwald E; Ellinor PT; Lubitz SA; Ruff CT; Sabatine MS
    JAMA Cardiol; 2022 Mar; 7(3):250-256. PubMed ID: 34773460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines.
    Sathiyakumar V; Park J; Quispe R; Elshazly MB; Michos ED; Banach M; Toth PP; Whelton SP; Blumenthal RS; Jones SR; Martin SS
    Circulation; 2018 Jul; 138(3):244-254. PubMed ID: 29506984
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.